Aptamer inhibits degradation of platelet proteolytically activatable receptor, PAR-1, by thrombin

Thrombosis Research

Volumn 104, Issue 3, 2001, Pages 215-222

  Boncler, Magdalena A ^a   Koziolkiewicz, Maria ^b   Watala, Cezary ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b CENTRE OF MOLECULAR AND MACROMOLECULAR STUDIES   (Poland)

Author keywords

Aptamer; Flow cytometry; Oligonucleotide; Platelet aggregation; Platelet thrombin receptor (PAR 1); Thrombin antagonist; Thrombin time

Indexed keywords

APTAMER; FIBRINOGEN; OLIGONUCLEOTIDE; PROTEINASE ACTIVATED RECEPTOR 1; SINGLE STRANDED DNA; THROMBIN; THROMBIN INHIBITOR;

ADULT; ARTICLE; BLOOD CLOTTING TIME; CATALYSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEGRANULATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; MALE; MOLECULAR SIZE; PRIORITY JOURNAL; PROTEIN DEGRADATION; THROMBIN TIME; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE MEMBRANE;

ADULT; APTAMERS, NUCLEOTIDE; BLOOD COAGULATION TESTS; BLOOD PLATELETS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FEMALE; FIBRIN; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDES; PLATELET AGGREGATION; RECEPTOR, PAR-1; RECEPTORS, THROMBIN; THROMBIN;

EID: 0035500890     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(01)00357-7     Document Type: Article

References (14)

1. Selection of single-stranded DNA molecules that bind and inhibit human thrombin
2. Pilot study of the efficacy of a thrombin inhibitor for use during cardiopulmonary bypass
3. A novel nucleotide-based thrombin inhibitor inhibits clot-bound thrombin and reduces arterial platelet thrombus formation
4. In vivo anticoagulant properties of a novel nucleotide-based thrombin inhibitor and demonstration of regional anticoagulation in extracorporeal circuits
5. The tertiary structure of a DNA aptamer which binds to and inhibits thrombin determines activity
6. The single-stranded DNA aptamer-binding site of human thrombin
7. Localization of the single-stranded DNA binding site in the thrombin anion-binding exosite
8. Thrombin receptors on human platelets. Initial localization and subsequent redistribution during platelet activation
9. Isolation of fibrinogen from plasma
10. Phosphorothioate oligonucleotides
11. Membrane lipid fluidity of blood platelets: A common denominator underlying the opposite actions of various agents affecting platelet activation in whole blood
12. Release of calcium and P-selectin from intraplatelet granules is hampered by procaine
13. Thrombin receptor: A novel target for antiplatelet drug development
14. Oligonucleotide inhibitors of human thrombin that bind distinct epitopes